In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Resmed (RMD – Research Report), with a price target of $280.00. The company’s shares closed yesterday at $257.65.

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Resmed (RMD – Research Report) today and set a price target of $250.00. The company’s shares closed yesterday at $257.65.

Qualified contracts—those held in individual retirement accounts (IRAs) or other tax-advantaged plans, like 401(k)s—are subject to the same required minimum distribution (RMD) rules as other ...

The Madison Metropolitan School District is in the process of updating mascot logos for its four largest public high schools, ...

PORTAGE, MI — Portage Public Schools is switching to new branding. The district’s new branding was presented at a Monday, Jan ...

So, no matter how early you file, remember that the federal tax return deadline (Tax Day) is April 15th, 2025. The federal ...

Dehradun: A religious certificate from clergy members will be required at the time of registering a live-in relationship only if the partners have a pre-existing relation falling under the ...

PORTLAND, Ore. (KPTV) - Community members are continuing to demand answers to a controversial drug outreach program in a Portland school zone. FOX 12 Investigates first took a close look at the ...

Investors should not necessarily draw any conclusions about the funds' investment performance from the amount of these distributions. Each fund estimates that a portion of its distribution does ...

After hours: 31 January at 7:54:27 pm GMT-5 ...

Marvel's Spider-Man 2 is available to PC players on January 30, 2025 on Steam and the Epic Games Store. Developed by Nixxes, this version offers PC-enhanced features to Insomniac's game, including ...